Sinovac nabs Chinese vaccine tenders for hep A, influenza

It's a good week to be Sinovac, which has won a pair of vaccine tenders in China. On Monday, the company announced that the Beijing Health Bureau had declared it the sole supplier of inactivated hepatitis A vaccine to its Expanded Program of Immunization--a tender worth about 16 million RMB ($2.6 million). And on Wednesday, Beijing's Centers for Disease Control and Prevention selected it as a supplier of seasonal flu vaccines. Release | Release

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.